2019 News

UKI2S, Catapult Ventures and Jonathan Milner invest £500k in Gene Modulation Newcomer Pencil Biosciences

11th December, 2019, Alderley Park: UK Innovation & Science Seed Fund (UKI2S), Catapult Ventures’ GM&C Life Sciences Fund and Jonathan Milner are pleased to announced an investment in Pencil Biosciences, a novel gene modulation com...

The AMR Centre's Dr Peter Jackson in Laboratory News

Moving from Push to Pull Nothing less than an entirely new model of drug development is needed if we are to create new antibiotics says Dr Peter Jackson. And it’s something NICE are finally taking seriously as they set about developin...

AMR Centre - World Antibiotic Awareness Week

This week is World Antibiotic Awareness Week. Watch the video produced by the AMR Centre here:  

AMR Centre candidate targets superbugs with problem metallo-β-lactamase enzymes

Alderley Park, UK, 11 November 2019   The AMR Centre has nominated a preclinical candidate in its program that tackles drug resistance conferred by NDM-1 and other metallo-β-lactamases (MBL).  The MBL inhibitor (MBLI) re...

Nexus Labs selected for prestigious Accelerator Programme at Alderley Park

We are delighted to share that Nexus Labs has been selected for the prestigious Accelerator Programme at Alderley Park, powered by BioCity. represented by CEO Glyn Estebanez, Nexus will be one of 7 high-potential li...

From our portfolio

metaLinear

Biotechnology

viewview our portfolio

Our Team

Dr Gareth King

view complete team

Contact us

Alderley Park
Alderley Edge
Cheshire
SK10 4TG

Tel: 01625 344300

email